StreetInsider.com News Articles

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast

Thu, 23 Jul 2026 10:00:00 -0400

RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast

Thu, 23 Jul 2026 10:00:00 -0400

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the

Form 4 Indivior Pharmaceuticals For: Jul 10 Filed by: Heidbreder Christian

Mon, 13 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260713/26762847.html

Form 4 Indivior Pharmaceuticals For: Jul 10 Filed by: Heidbreder Christian

Mon, 13 Jul 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260713/26762847.html

Form 144 Indivior Pharmaceuticals Filed by: Heidbreder Christian

Fri, 10 Jul 2026 10:02:00 -0400

si-local-file:///var/storage/secattach/20260710/26755867.html

Form 144 Indivior Pharmaceuticals Filed by: Heidbreder Christian

Fri, 10 Jul 2026 10:02:00 -0400

si-local-file:///var/storage/secattach/20260710/26755867.html

Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph

Tue, 23 Jun 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260623/26680667.html

Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph

Tue, 23 Jun 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260623/26680667.html

Barclays Starts Indivior (INDV) at Overweight

Thu, 18 Jun 2026 04:25:05 -0400

Barclays analyst Glen Santangelo initiates coverage on Indivior (NASDAQ: INDV) with a Overweight rating and a price target of $46.00.

The analyst comments: “Indivior has undergone a transformation following the appointment of CEO Joe Ciaffoni last summer, the rollout of the Indivior Action Agenda and the transition to a US listing earlier this year. While these positive developments have certainly contributed to the stock's impressive performance – +168% over the past 12 months (S&P +25%) – we believe the company’s core fundamentals and outlook remain somewhat underappreciated. Looking ahead, we expect additional beats and raises plus repo, which should contribute to

Barclays Starts Indivior (INDV) at Overweight

Thu, 18 Jun 2026 04:25:05 -0400

Barclays analyst Glen Santangelo initiates coverage on Indivior (NASDAQ: INDV) with a Overweight rating and a price target of $46.00.

Form 4 Indivior Pharmaceuticals For: Jun 11 Filed by: Heidbreder Christian

Fri, 12 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260612/26640840.html

Form 4 Indivior Pharmaceuticals For: Jun 11 Filed by: Heidbreder Christian

Fri, 12 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260612/26640840.html

Form 144 Indivior Pharmaceuticals Filed by: Heidbreder Christian

Thu, 11 Jun 2026 11:20:00 -0400

si-local-file:///var/storage/secattach/20260611/26634242.html

Form 144 Indivior Pharmaceuticals Filed by: Heidbreder Christian

Thu, 11 Jun 2026 11:20:00 -0400

si-local-file:///var/storage/secattach/20260611/26634242.html

Form 4 Indivior Pharmaceuticals For: Jun 08 Filed by: Preblick Ryan

Wed, 10 Jun 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260610/26626149.html

Form 4 Indivior Pharmaceuticals For: Jun 08 Filed by: Preblick Ryan

Wed, 10 Jun 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260610/26626149.html

Form 144/A Indivior Pharmaceuticals Filed by: Preblick Ryan

Mon, 08 Jun 2026 15:24:00 -0400

si-local-file:///var/storage/secattach/20260608/26616927.html

Form 144/A Indivior Pharmaceuticals Filed by: Preblick Ryan

Mon, 08 Jun 2026 15:24:00 -0400

si-local-file:///var/storage/secattach/20260608/26616927.html

Form 144 Indivior Pharmaceuticals Filed by: Preblick Ryan

Mon, 08 Jun 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260608/26616559.html

Form 144 Indivior Pharmaceuticals Filed by: Preblick Ryan

Mon, 08 Jun 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260608/26616559.html

New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization